About this Research Topic
Frontiers has organized a series of Research Topics to highlight the latest advancements in research across the field of genetics, with articles from the members of our accomplished Editorial Boards and the broader research community. This Research Topic series focuses on new insights, developments, challenges, latest discoveries, recent advances, and future perspectives in the field of human and medical genomics. Led by Dr. Jared Roach and Dr. Maxim Freydin, Specialty Chief Editors of the Human and Medical Genomics section in Frontiers in Genetics, this Research Topic aims to illuminate the strides made over the past decade within the realm of human and medical genomics field, providing a comprehensive overview of past achievements while dissecting future challenges. The primary focus is to showcase progress and pinpoint the existing hurdles that still need to be surmounted to push the boundaries of what's medically and technically feasible in genetics.
To gather further insights within this rapidly developing field, we welcome articles addressing, but not limited to, the following themes:
• Novel genomic technologies and their clinical application
• Genetic determinants of complex diseases
• Ethical, legal, and social implications of genomic research
• Personalized medicine and genomic tailoring
• Advances in genomic sequencing techniques
• Integration of genomic data with AI and machine learning approaches
These contributions should reflect the state-of-the-art, detail recent developments, and highlight pivotal accomplishments, emphasizing on advancing knowledge and applications within the field.
Keywords: genomics, systems biology, multiomics, translational science, genomic medicine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.